FDAnews
www.fdanews.com/articles/142282-sanofi-rebuffs-renewed-lantus-cancer-worries

Sanofi Rebuffs Renewed Lantus Cancer Worries

December 7, 2011
A Swedish study has rekindled concerns about a possible link between Sanofi’s top-selling insulin drug Lantus and cancer, but the French drugmaker said Wednesday the observational research was seriously flawed.
Fox News